1. Home
  2. IPGP vs OGN Comparison

IPGP vs OGN Comparison

Compare IPGP & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPGP
  • OGN
  • Stock Information
  • Founded
  • IPGP 1990
  • OGN 1923
  • Country
  • IPGP United States
  • OGN United States
  • Employees
  • IPGP N/A
  • OGN N/A
  • Industry
  • IPGP Semiconductors
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPGP Technology
  • OGN Health Care
  • Exchange
  • IPGP Nasdaq
  • OGN Nasdaq
  • Market Cap
  • IPGP 3.2B
  • OGN 2.7B
  • IPO Year
  • IPGP 2006
  • OGN N/A
  • Fundamental
  • Price
  • IPGP $82.46
  • OGN $10.80
  • Analyst Decision
  • IPGP Buy
  • OGN Hold
  • Analyst Count
  • IPGP 7
  • OGN 4
  • Target Price
  • IPGP $77.60
  • OGN $18.00
  • AVG Volume (30 Days)
  • IPGP 227.5K
  • OGN 3.6M
  • Earning Date
  • IPGP 10-28-2025
  • OGN 10-30-2025
  • Dividend Yield
  • IPGP N/A
  • OGN 0.76%
  • EPS Growth
  • IPGP N/A
  • OGN N/A
  • EPS
  • IPGP N/A
  • OGN 2.69
  • Revenue
  • IPGP $945,994,000.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • IPGP $0.32
  • OGN N/A
  • Revenue Next Year
  • IPGP $7.22
  • OGN $1.36
  • P/E Ratio
  • IPGP N/A
  • OGN $3.90
  • Revenue Growth
  • IPGP N/A
  • OGN N/A
  • 52 Week Low
  • IPGP $48.59
  • OGN $8.01
  • 52 Week High
  • IPGP $88.50
  • OGN $20.96
  • Technical
  • Relative Strength Index (RSI)
  • IPGP 56.16
  • OGN 66.66
  • Support Level
  • IPGP $79.69
  • OGN $10.24
  • Resistance Level
  • IPGP $83.35
  • OGN $10.95
  • Average True Range (ATR)
  • IPGP 2.12
  • OGN 0.41
  • MACD
  • IPGP -0.31
  • OGN 0.08
  • Stochastic Oscillator
  • IPGP 64.31
  • OGN 92.08

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: